Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 1/2015

01-02-2015 | Correspondence

Fatal lactic acidosis associated with linezolid therapy

Authors: M. Djibré, T. Pham, M. Denis, V. Pras Landre, M. Fartoukh

Published in: Infection | Issue 1/2015

Login to get access

Excerpt

To the Editor …
Literature
1.
2.
Contou D, Fichet J, Grimaldi D, et al. Early life-threatening lactic acidosis following a single infusion of linezolid. Int J Antimicrob Agents. 2011;38:84–5.PubMedCrossRef
3.
De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis. 2006;42:1111–7.PubMedCrossRef
4.
Boutoille D, Grossi O, Depatureaux A, et al. Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis. Eur J Intern Med. 2009;20:e134–5.PubMedCrossRef
5.
Wiener M, Guo Y, Patel G, et al. Lactic acidosis after treatment with linezolid. Infection. 2007;35:278–81.PubMedCrossRef
Metadata
Title
Fatal lactic acidosis associated with linezolid therapy
Authors
M. Djibré
T. Pham
M. Denis
V. Pras Landre
M. Fartoukh
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2015
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0692-3

Other articles of this Issue 1/2015

Infection 1/2015 Go to the issue

Original Paper

Influence of intimal Chlamydophila pneumoniae persistence on cardiovascular complications after coronary intervention

Original Paper

Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis

Original Paper

Oseltamivir prophylaxis in controlling influenza outbreak in nursing homes: a comparison between three different approaches

Case Report

Severe Staphylococcus lugdunensis keratitis

Original Paper

Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany

Brief Report

Severe thrombocytopenia in hantavirus-induced nephropathia epidemica

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits